Intravenous Iron: Evaluation of the Use of Saccharated Iron Oxide in Iron Deficiency States in Obstetrics and Gynecology
Open Access
- 1 November 1951
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 6 (11) , 1159-1172
- https://doi.org/10.1182/blood.v6.11.1159.1159
Abstract
Saccharated iron oxide has been given to 23 patients in doses of 480 to 1,430 mg. Toxic symptoms were minimal. Hematologic response was good in 21 patients. Continued bleeding accounted for the poor response in 2 persons. Saccharated iron oxide is a safe preparation for clinical use. It is easy to administer. Further clinical evaluation is warranted. Excessive amounts of intravenous iron should not be given to any individual.Keywords
This publication has 9 references indexed in Scilit:
- IRON METABOLISMBlood, 1949
- INTRAVENOUS ADMINISTRATION OF IRONThe Lancet, 1947
- Its Absorption, Storage and Utilization in Experimental AnemiaThe Lancet Healthy Longevity, 1935
- I IRON AND ITS UTILIZATION IN EXPERIMENTAL ANEMIAThe Lancet Healthy Longevity, 1935
- QUANTITATIVE ASPECTS OF IRON DEFICIENCY IN HYPOCHROMIC ANEMIAJournal of Clinical Investigation, 1932
- The late results of intravenous injection of colloidal ironThe Journal of Pathology and Bacteriology, 1930
- Intravitam and supravital staining. I. The principles and general resultsThe Journal of Pathology and Bacteriology, 1929
- The fate of colloidal iron administered intravenously. Part II: Long experimentsThe Journal of Pathology and Bacteriology, 1929
- The fate of colloidal iron administered intravenouslyThe Journal of Pathology and Bacteriology, 1928